- Home
- / Forte Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Forte Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.6
2024-10-29
Market Capitalization
$6.7 M
2024-10-29
Revenue
$36 K
FY, 2019
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.0K | 18.0M | 36.0K | ||||||
| General and administrative expense | 8.6M | 12.8M | 16.2M | 4.2M | 7.6M | 8.3M | 10.6M | 15.4M | 12.4M |
| Operating expense total | 37.7M | 63.9M | 61.5M | 14.2M | 13.9M | 36.1M | 70.1M | ||
| EBIT | (37.6M) | (45.9M) | (61.5M) | (46.3M) | (21.5M) | (13.9M) | (32.5M) | (36.6M) | (70.7M) |
| EBIT margin, % | -91778.0% | -254.2% | -170863.9% | ||||||
| Interest income | 595.0K | 1.5M | 1.6M | ||||||
| Interest expense | 1.1M | 1.3M | 2.7M | ||||||
| Pre tax profit | (47.3M) | (63.5M) | (35.5M) | (68.3M) | |||||
| Income tax expense | 1.7M | 1.0K | 1.0M | ||||||
| Net Income | (38.9M) | (49.0M) | (63.5M) | (46.5M) | (21.7M) | (13.9M) | (31.5M) | (35.5M) | (69.4M) |
| EPS | (0.8) | (1.0) | (12.2) | (4.7) |